Guo Jin
commented on
$GameStop(GME.US$ whats keeping gme down??!
10
Guo Jin
commented on
$ObsEva SA(OBSV.US$ ObsEva (OBSV) said on Thursday that data from its proof-of-concept trial showed the potential of ebopiprant as a treatment for spontaneous premature births.
In a phase 2a study, ebopiprant was found to be well tolerated and has shown early evidence of efficacy. The statement said that compared to using Atosiban alone, the candidate drug for injecting premature women with atosiban reduced the delivery rate of single pregnancies by more than 50% within 48 hours of starting administration.
These data were presented at the 2021 Royal College of Obstetrics and Gynecology Virtual World Congress.
Shares of the biopharmaceutical company rose more than 3% during Thursday's recent pre-market event. ObsEva (OBSV) said on Thursday that data from its proof-of-concept trial showed the potential of ebopiprant as a treatment for spontaneous premature births.
In a phase 2a study, ebopiprant was found to be well tolerated and has shown early evidence of efficacy. The statement said that compared to using Atosiban alone, the candidate drug for injecting premature women with atosiban reduced the delivery rate of single pregnancies by more than 50% within 48 hours of starting administration.
These data were presented at the 2021 Royal College of Obstetrics and Gynecology Virtual World Congress.
Shares of the biopharmaceutical company rose more than 3% during Thursday's recent pre-market event.
In a phase 2a study, ebopiprant was found to be well tolerated and has shown early evidence of efficacy. The statement said that compared to using Atosiban alone, the candidate drug for injecting premature women with atosiban reduced the delivery rate of single pregnancies by more than 50% within 48 hours of starting administration.
These data were presented at the 2021 Royal College of Obstetrics and Gynecology Virtual World Congress.
Shares of the biopharmaceutical company rose more than 3% during Thursday's recent pre-market event. ObsEva (OBSV) said on Thursday that data from its proof-of-concept trial showed the potential of ebopiprant as a treatment for spontaneous premature births.
In a phase 2a study, ebopiprant was found to be well tolerated and has shown early evidence of efficacy. The statement said that compared to using Atosiban alone, the candidate drug for injecting premature women with atosiban reduced the delivery rate of single pregnancies by more than 50% within 48 hours of starting administration.
These data were presented at the 2021 Royal College of Obstetrics and Gynecology Virtual World Congress.
Shares of the biopharmaceutical company rose more than 3% during Thursday's recent pre-market event.
Translated
1
1
Guo Jin
reacted to
In the previous article, you learned about the important SEC filings and how they could assist trading decisions. But when you download the files and first open the documents, you could be surprised by the size of them, which can often be in excess of 100 pages.
However, all of these filings are divided into easy-to-understand sections in order to make them easier to follow, and here are some tips on how you can fast-read SEC filings.
Sections of SEC filings...
However, all of these filings are divided into easy-to-understand sections in order to make them easier to follow, and here are some tips on how you can fast-read SEC filings.
Sections of SEC filings...
![How to quickly spot key information in SEC filings?](https://ussnsimg.moomoo.com/moo-1623294274-77777015-iPhone-1-org.jpg/thumb)
![How to quickly spot key information in SEC filings?](https://ussnsimg.moomoo.com/16232936569542-77777015-web-f46d35d408c20f28.png/thumb)
![How to quickly spot key information in SEC filings?](https://ussnsimg.moomoo.com/16232939580648-77777015-web-7648ee71f93c54d9.png/thumb)
+1
97
11
Guo Jin
liked